Ziv-aflibercept
Generic name: Ziv-aflibercept
Brand names: Zaltrap
Dosage form: intravenous solution (25 mg/mL)
Drug class:
VEGF/VEGFR inhibitors
Usage of Ziv-aflibercept
Ziv-aflibercept is used in combination chemotherapy to treat colorectal cancer that has spread to other parts of the body (metastatic).
Ziv-aflibercept is usually given after other medications did not work or have stopped working.
Ziv-aflibercept may also be used for purposes not listed in this medication guide.
Ziv-aflibercept side effects
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Ziv-aflibercept can make it easier for you to bleed. Call your doctor or seek emergency medical attention if you have:
Ziv-aflibercept may cause serious side effects. Call your doctor at once if you have:
Older adults may be more likely to have severe diarrhea or get dehydrated.
Your cancer treatments may be delayed or permanently discontinued if you have certain side effects.
Common side effects of ziv-aflibercept may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Ziv-aflibercept
Tell your doctor if you have ever had:
Ziv-aflibercept may harm an unborn baby. You may need to have a negative pregnancy test before starting this treatment. Use effective birth control to prevent pregnancy while using ziv-aflibercept and for at least 1 month after your last dose. Tell your doctor if you become pregnant.
Pregnancy may be less likely to occur while the mother or the father is using this medicine. Women should still use birth control to prevent pregnancy because the medicine can harm an unborn baby.
You should not breastfeed while you are using ziv-aflibercept, and for at least 1 month after your last dose.
Relate drugs
- Alymsys
- Alymsys (Bevacizumab Intravenous)
- Alymsys (Bevacizumab-maly Intravenous)
- Avastin
- Cyramza
- Mvasi
- Mvasi (Bevacizumab Intravenous)
- Mvasi (Bevacizumab-awwb Intravenous)
- Bevacizumab
- Bevacizumab-adcd
- Bevacizumab-awwb
- Bevacizumab-bvzr
- Bevacizumab-maly
- Fotivda
- Pazopanib
- Ramucirumab
- Tivozanib
- Vegzelma
- Vegzelma (Bevacizumab Intravenous)
- Vegzelma (Bevacizumab-adcd Intravenous)
- Votrient
- Zaltrap
- Zirabev
- Zirabev (Bevacizumab Intravenous)
- Zirabev (Bevacizumab-bvzr Intravenous)
- Ziv-aflibercept
How to use Ziv-aflibercept
Usual Adult Dose for Colorectal Cancer:
4 mg/kg IV over 1 hour every 2 weeks; administer this drug prior to any component of the FOLFIRI regimen on the day of treatment -Duration of therapy: until disease progression or unacceptable toxicityUse: This drug in combination with 5-fluorouracil, leucovorin, irinotecan-(FOLFIRI), is indicated for patients with metastatic colorectal cancer (mCRC) that is resistant to or has progressed following an oxaliplatin-containing regimen
Warnings
Ziv-aflibercept may cause serious and sometimes fatal bleeding. Call your doctor at once if you have any signs of unusual bleeding, including easy bruising, bloody stools, coughing up blood, or feeling light-headed or short of breath.
If you need surgery, tell the surgeon ahead of time that you are using ziv-aflibercept.
What other drugs will affect Ziv-aflibercept
Other drugs may affect ziv-aflibercept, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions